Hepatitis B, HIV, and Syphilis Seroprevalence in Pregnant Women and Blood Donors in Cameroon

Table 2

Results of screening tests in pregnant women and blood donors, (%) (95% CI).

(a)

Pregnant women	Mboppi; ()	Mbingo; ()	Mutengene; ()	Banso; ()	value	Total; ()
Hepatitis B	184 (4.3); (3.7, 5.0)	14 (1.1); (0.6, 1.9)	84 (9.6); (7.7, 11.8)	26 (3.6); (2.3, 5.2)	<0.0001	308 (4.4); (3.9, 4.9)
HIV	252 (5.9); (5.3, 6.7)	56 (4.6); (3.5, 5.9)	89 (10.2); (8.3, 12.4)	22 (3.0); (1.9, 4.6)	<0.0001	413 (6.0); (5.3, 6.4)
Syphilis	57 (1.3); (1.0, 1.7)	17 (1.4); (0.8, 2.2)	33 (3.8); (2.6, 5.3)	15 (2.1); (1.2, 3.4)	<0.0001	122 (1.7); (1.4, 2.1)

(b)

Blood donors	()	()	()	()	value	()
Hepatitis B	50 (5.8); (4.3, 4.6)	115 (8.8); (7.3, 10.5)	64 (7.2); (5.6, 9.1)	58 (5.0); (3.8, 6.4)	0.001	287 (6.8); (6.1, 7.6)
HIV	24 (2.8); (1.8, 4.1)	30 (2.3); (1.6, 3.3)	24 (2.7); (1.7, 4.0)	16 (1.4); (0.7, 2.2)	0.11	94 (2.2); (1.8, 2.7)
Syphilis	39 (4.5); (3.2, 6.1)	43 (3.3); (1.7, 3.4)	40 (4.5); (3.2, 6.1)	46 (3.9); (2.9, 5.2)	0.40	168 (4.0); (3.4, 4.6)
Hepatitis C	20 (2.3); (1.4, 3.6)	32 (2.5); (2.4, 4.4)	4 (0.5); (0.01, 1.2)	15 (1.3); (0.7, 2.1)	0.001	71 (1.7); (1.3, 2.1)
Malaria	N/A	N/A	N/A	22 (1.9)	N/A	22/1170 (1.9); (1.2, 2.8)

Infections are not mutually exclusive; coinfection data is discussed in Section 3.